Paul J. Wang

Advances in implantable cardioverter defibrillators.

Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.

Effects of estrogen on cardiac electrophysiology in female mice.

Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs.

Assessment of risk for sudden cardiac death.

Inducible ventricular flutter and fibrillation predict for arrhythmia occurrence in coronary artery disease patients presenting with syncope of unknown origin.

Cardiology patient pages. Supraventricular tachycardia.

Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis).

Evidence that nonsustained polymorphic ventricular tachycardia causes syncope (data from implantable cardioverter defibrillators).

Automated external defibrillator arrhythmia detection in a model of cardiac arrest due to commotio cordis.

Tufts Health Sciences Database: lessons, issues, and opportunities.

Use of antiarrhythmics and implantable cardioverter-defibrillators in congestive heart failure.

Use of the AutoCapture Pacing System with implantable defibrillator leads.

Inappropriate shock and pacing?

Cardiac arrhythmias in the athlete: the evolving role of electrophysiology.

Testing of a new T-wave subtraction algorithm as an aid to localizing ectopic atrial beats.

Herbal medicine: beneficial effects, side effects, and promising new research in the treatment of arrhythmias.

Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.

Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.

Frequent ICD shocks due to double sensing in patients with bi-ventricular implantable cardioverter defibrillators.

Durability of repaired sensing leads equivalent to that of new leads in implantable cardioverter defibrillator patients with sensing abnormalities.

Syncope in the patient with nonischemic dilated cardiomyopathy.

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.

Electrocardiographic arrhythmia risk testing.

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.

Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation.

Rhythm classification by correlation-waveform morphology analysis of atrial and ventricular electrogram signals.

Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.

Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis).

Extraction of buried P waves from printed electrocardiograms.

Loss of biventricular pacing: what is the cause?

Atrial pacing above the sensor rate: what is the cause?

Early experience with a computerized robotically controlled catheter system.

Use of the implantable cardioverter-defibrillator in long-term survivors of orthotopic heart transplantation.

Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.

Atrioventricular nodal reverse facilitation in connexin40-deficient mice.

Delivery of antitachycardia pacing after a full-energy shock during the same ventricular tachycardia episode: appropriate device function?

Atrial fibrillation, sleep apnea and obesity.

Regionally specific atrophy of the corpus callosum in AD, MCI and cognitive complaints.

Premature ventricular contractions causing pacemaker-mediated tachycardia: a failure of postventricular atrial refractory period after premature ventricular contraction extension?

Supraventricular tachycardia vs ventricular tachycardia: what is the rhythm?

Rate control: is local better?

Cryoablation of the pulmonary veins using a novel balloon catheter.

Early human experience with use of a deflectable fiberoptic endocardial visualization catheter to facilitate coronary sinus cannulation.

Isolated giant cell myocarditis in the atrium: an incidental finding?

Inappropriate shock: a failure of SVT discriminators in a dual chamber ICD?

VF and fatal cardiac arrest following ICD therapy delivery: what is the cause?

The CREB leucine zipper regulates CREB phosphorylation, cardiomyopathy, and lethality in a transgenic model of heart failure.

Characterization of human coronary sinus valves by direct visualization during biventricular pacemaker implantation.

Time-resolved three-dimensional imaging of the left atrium and pulmonary veins in the interventional suite--a comparison between multisweep gated rotational three-dimensional reconstructed fluoroscopy and multislice computed tomography.

Pacemaker alternans terminated by telemetry wand: what is the mechanism?

Optimal Programming of ICDs for Prevention of Appropriate and Inappropriate Shocks.

Visualizing ablation gaps in vitro using a deflectable fiber optic endocardial visualization catheter.

"Low ejection fraction prophylaxis" with implantable defibrillators in the elderly: call for a randomized trial?

Electrocardiographic predictors of atrial fibrillation.

Measurement precision in the optimization of cardiac resynchronization therapy.

Inappropriate pacing in a patient with managed ventricular pacing: what is the cause?

Direct visualization of cardiac radiofrequency ablation lesions.

Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT.

Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.

Cost-effectiveness of genetic testing in family members of patients with long-QT syndrome.

A novel method for patient-specific QTc--modeling QT-RR hysteresis.

Subcutaneous implantable cardioverter-defibrillator technology.

Intraprocedure visualization of the esophagus using interventional C-arm CT as guidance for left atrial radiofrequency ablation.

Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).

Guidance for the Heart Rhythm Society pertaining to interactions with industry endorsed by the Heart Rhythm Society on April 26, 2011.

Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).

Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation.

Ability of microvolt T-wave alternans to modify risk assessment of ventricular tachyarrhythmic events: a meta-analysis.

Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).

Latency of ECG displays of hospital telemetry systems: a science advisory from the American Heart Association.

Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial.

Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.

Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.

Outcomes from a postgraduate biomedical technology innovation training program: the first 12 years of Stanford Biodesign.

ATP during charging: a failure of therapy?

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Dyssynchrony and the risk of ventricular arrhythmias.

Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D.

Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women's Health Initiative Observational Study.

Palpitations in a patient with a dual-chamber pacemaker: what is the mechanism?

Shock-induced ventricular tachycardia: what is the mechanism?

Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT.

Association between success rate and citation count of studies of radiofrequency catheter ablation for atrial fibrillation: possible evidence of citation bias.

Highly skin-conformal microhairy sensor for pulse signal amplification.

Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Hybrid epicardial and endocardial ablation of atrial fibrillation: is ablation on two sides of the atrial wall better than one?

Feasibility of Extended Ambulatory Electrocardiogram Monitoring to Identify Silent Atrial Fibrillation in High-risk Patients: The Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF).

Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) Trial.